{"id":"https://openalex.org/W3193977597","doi":"https://doi.org/10.2217/cer-2021-0131","title":"Comparative effectiveness analysis between entrectinib clinical trial and crizotinib real-world data inROS1+ NSCLC","display_name":"Comparative effectiveness analysis between entrectinib clinical trial and crizotinib real-world data inROS1+ NSCLC","publication_year":2021,"publication_date":"2021-08-24","ids":{"openalex":"https://openalex.org/W3193977597","doi":"https://doi.org/10.2217/cer-2021-0131","mag":"3193977597","pmid":"https://pubmed.ncbi.nlm.nih.gov/34427452"},"language":"en","primary_location":{"id":"doi:10.2217/cer-2021-0131","doi":"https://doi.org/10.2217/cer-2021-0131","is_oa":true,"landing_page_url":"https://doi.org/10.2217/cer-2021-0131","pdf_url":null,"source":{"id":"https://openalex.org/S2489859990","display_name":"Journal of Comparative Effectiveness Research","issn_l":"2042-6305","issn":["2042-6305","2042-6313"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Comparative Effectiveness Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.2217/cer-2021-0131","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034705456","display_name":"Robert Charles Doebele","orcid":"https://orcid.org/0000-0001-6728-6857","observed_orcids":["https://orcid.org/0000-0001-6728-6857"]},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert C Doebele","raw_affiliation_strings":["Anschutz Medical Campus,\u00a0University of Colorado, 1665 Aurora Court Anschutz Cancer Pavilion, Aurora, CO 80045, USA"],"raw_orcid":"https://orcid.org/0000-0001-6728-6857","affiliations":[{"raw_affiliation_string":"Anschutz Medical Campus,\u00a0University of Colorado, 1665 Aurora Court Anschutz Cancer Pavilion, Aurora, CO 80045, USA","institution_ids":["https://openalex.org/I51713134"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054828796","display_name":"Laura Mezquita P\u00e9rez","orcid":"https://orcid.org/0000-0002-1695-7494","observed_orcids":["https://orcid.org/0000-0002-1695-7494"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Laura Perez","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073889590","display_name":"Huong Trinh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Huong Trinh","raw_affiliation_strings":["Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080636105","display_name":"Michael Martinec","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Michael Martinec","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085188200","display_name":"Reynaldo Martina","orcid":"https://orcid.org/0000-0002-1925-820X","observed_orcids":["https://orcid.org/0000-0002-1925-820X"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Reynaldo Martina","raw_affiliation_strings":["Department of Biostatistics,\u00a0University of Liverpool, Liverpool, L69 3BX, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics,\u00a0University of Liverpool, Liverpool, L69 3BX, UK","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113882339","display_name":"Todd Riehl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Todd Riehl","raw_affiliation_strings":["Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080991347","display_name":"Matthew Krebs","orcid":"https://orcid.org/0000-0001-7540-3064","observed_orcids":["https://orcid.org/0000-0001-7540-3064"]},"institutions":[{"id":"https://openalex.org/I2799725268","display_name":"Manchester Academic Health Science Centre","ror":"https://ror.org/04rrkhs81","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799725268"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Matthew G Krebs","raw_affiliation_strings":["Division of Cancer Sciences, Faculty of Biology, Medicine & Health, The University of Manchester & The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, M20 4BX, UK"],"raw_orcid":"https://orcid.org/0000-0001-7540-3064","affiliations":[{"raw_affiliation_string":"Division of Cancer Sciences, Faculty of Biology, Medicine & Health, The University of Manchester & The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, M20 4BX, UK","institution_ids":["https://openalex.org/I2799725268","https://openalex.org/I28407311","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053128814","display_name":"Neal J. Meropol","orcid":"https://orcid.org/0000-0001-6353-7364","observed_orcids":["https://orcid.org/0000-0001-6353-7364"]},"institutions":[{"id":"https://openalex.org/I4210153546","display_name":"Flatiron Health (United States)","ror":"https://ror.org/0508h6p74","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153546"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neal J Meropol","raw_affiliation_strings":["Flatiron Health, Inc., 233 Spring Street, New York,\u00a0NY 10013, USA"],"raw_orcid":"https://orcid.org/0000-0001-6353-7364","affiliations":[{"raw_affiliation_string":"Flatiron Health, Inc., 233 Spring Street, New York,\u00a0NY 10013, USA","institution_ids":["https://openalex.org/I4210153546"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025997705","display_name":"William Bruce Wong","orcid":"https://orcid.org/0000-0002-6054-278X","observed_orcids":["https://orcid.org/0000-0002-6054-278X"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William B Wong","raw_affiliation_strings":["Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA"],"raw_orcid":"https://orcid.org/0000-0002-6054-278X","affiliations":[{"raw_affiliation_string":"Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023655314","display_name":"Gracy Crane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113058","display_name":"Roche (United Kingdom)","ror":"https://ror.org/024tgbv41","country_code":"GB","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210113058"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gracy Crane","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, Hexagon Place, Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Hexagon Place, Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, UK","institution_ids":["https://openalex.org/I4210113058"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.2698,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.89054515,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"10","issue":"17","first_page":"1271","last_page":"1282"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/entrectinib","display_name":"entrectinib","score":0.9909999966621399},{"id":"https://openalex.org/keywords/crizotinib","display_name":"crizotinib","score":1.0},{"id":"https://openalex.org/keywords/time-to-treatment-discontinuation","display_name":"time to treatment discontinuation","score":0.7900000214576721},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.906000018119812},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9990000128746033},{"id":"https://openalex.org/keywords/real-world-data","display_name":"real-world data","score":0.5389999747276306},{"id":"https://openalex.org/keywords/clinical-trial-comparison","display_name":"clinical trial comparison","score":0.5199999809265137},{"id":"https://openalex.org/keywords/rare-tumor","display_name":"rare tumor","score":0.3370000123977661}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9200305938720703},{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.8909976482391357},{"id":"https://openalex.org/C2775999482","wikidata":"https://www.wikidata.org/wiki/Q18031208","display_name":"ROS1","level":4,"score":0.7386723756790161},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5393822193145752},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4859215319156647},{"id":"https://openalex.org/C3018095205","wikidata":"https://www.wikidata.org/wiki/Q55641553","display_name":"Real world evidence","level":2,"score":0.4581242799758911},{"id":"https://openalex.org/C3020493868","wikidata":"https://www.wikidata.org/wiki/Q55631277","display_name":"Real world data","level":2,"score":0.43690311908721924},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41350144147872925},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.31701913475990295},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.17084088921546936},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.14900529384613037},{"id":"https://openalex.org/C2522767166","wikidata":"https://www.wikidata.org/wiki/Q2374463","display_name":"Data science","level":1,"score":0.09927806258201599},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077547","descriptor_name":"Crizotinib","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007191","descriptor_name":"Indazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011518","descriptor_name":"Proto-Oncogene Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.2217/cer-2021-0131","doi":"https://doi.org/10.2217/cer-2021-0131","is_oa":true,"landing_page_url":"https://doi.org/10.2217/cer-2021-0131","pdf_url":null,"source":{"id":"https://openalex.org/S2489859990","display_name":"Journal of Comparative Effectiveness Research","issn_l":"2042-6305","issn":["2042-6305","2042-6313"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Comparative Effectiveness Research","raw_type":"journal-article"},{"id":"pmid:34427452","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34427452","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of comparative effectiveness research","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire/e1c8e5c3-2d15-4ca7-b0f7-ffba5be5401e","doi":null,"is_oa":true,"landing_page_url":"https://research.manchester.ac.uk/en/publications/e1c8e5c3-2d15-4ca7-b0f7-ffba5be5401e","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Doebele, R C, Perez, L, Trinh, H, Martinec, M, Martina, R, Riehl, T, Krebs, M G, Meropol, N J, Wong, W B & Crane, G 2021, 'Comparative effectiveness analysis between entrectinib clinical trial and crizotinib real-world data in ROS1 + NSCLC', Journal of Comparative Effectiveness Research. https://doi.org/10.2217/cer-2021-0131","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2217/cer-2021-0131","doi":"https://doi.org/10.2217/cer-2021-0131","is_oa":true,"landing_page_url":"https://doi.org/10.2217/cer-2021-0131","pdf_url":null,"source":{"id":"https://openalex.org/S2489859990","display_name":"Journal of Comparative Effectiveness Research","issn_l":"2042-6305","issn":["2042-6305","2042-6313"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Comparative Effectiveness Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309432","display_name":"F. Hoffmann-La Roche","ror":"https://ror.org/00by1q217"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1832172388","https://openalex.org/W1989734503","https://openalex.org/W2103447891","https://openalex.org/W2110818436","https://openalex.org/W2119317963","https://openalex.org/W2130488043","https://openalex.org/W2148332636","https://openalex.org/W2292803562","https://openalex.org/W2296023454","https://openalex.org/W2583931149","https://openalex.org/W2586704604","https://openalex.org/W2604438864","https://openalex.org/W2620947766","https://openalex.org/W2622325875","https://openalex.org/W2738833037","https://openalex.org/W2783592711","https://openalex.org/W2794491531","https://openalex.org/W2804210712","https://openalex.org/W2888401460","https://openalex.org/W2891508744","https://openalex.org/W2896449097","https://openalex.org/W2921982658","https://openalex.org/W2938245541","https://openalex.org/W2938450158","https://openalex.org/W2952455110","https://openalex.org/W2967365762","https://openalex.org/W2995220921","https://openalex.org/W2996574710"],"related_works":["https://openalex.org/W2981403738","https://openalex.org/W2947072829","https://openalex.org/W3138084973","https://openalex.org/W4214916868","https://openalex.org/W4404214345","https://openalex.org/W3042002926","https://openalex.org/W3110662873","https://openalex.org/W2996347928","https://openalex.org/W3112926054","https://openalex.org/W4401358118"],"abstract_inverted_index":{"Aim:Generating":[0],"direct":[1],"comparative":[2],"evidence":[3],"in":[4,95],"prospective":[5],"randomized":[6],"trials":[7,29,97],"is":[8],"difficult":[9],"for":[10,66,71],"rare":[11],"diseases.":[12],"Real-world":[13],"cohorts":[14],"may":[15,98],"supplement":[16],"control":[17],"populations.Methods:Entrectinib-treated":[18],"adults":[19],"with":[20,39,80,88,101],"advancedROS1fusion-positive":[21],"NSCLC":[22],"(n":[23,44],"=":[24,45],"94)":[25],"from":[26],"Phase":[27],"I/II":[28],"(ALKA-372-001":[30],"[EudraCT2012-00148-88],":[31],"STARTRK-1":[32],"[NCT02097810],":[33],"and":[34,57],"STARTRK-2":[35],"[NCT02568267])":[36],"were":[37],"compared":[38],"a":[40,105],"real-world":[41,106],"crizotinib-treated":[42],"cohort":[43],"65).":[46],"Primary":[47],"end":[48,54],"point,":[49],"time-to-treatment":[50],"discontinuation":[51],"(TTD);":[52],"secondary":[53],"points,":[55],"PFS":[56],"OS.Results:Median":[58],"(95%":[59],"CI)":[60],"weighted":[61,85],"TTD:":[62],"12.9":[63],"(9.9\u201317.4)":[64],"months":[65,70],"entrectinib;":[67],"8.2":[68],"(6.2\u20139.9)":[69],"crizotinib":[72,89,107],"(weighted":[73],"hazard":[74],"ratio:":[75],"0.72":[76],"[0.51\u20131.02]).":[77],"Median":[78],"OS":[79,87],"entrectinib":[81],"was":[82,90],"not":[83],"reached,":[84],"median":[86],"18.5":[91],"(15.1\u201347.2)":[92],"months.Conclusion:Entrectinib":[93],"administered":[94],"clinical":[96],"be":[99],"associated":[100],"longer":[102],"TTD":[103],"than":[104],"population.":[108]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-08-30T00:00:00"}